2019 American Transplant Congress Archives - Page 49 of 214

Development of Non-Human Leukocyte Antigen Antibodies in Cardiac Antibody-Mediated Rejection

S. B. See¹, B. S. Mantell², K. J. Clerkin³, B. Ray⁴, E. R. Vasilescu⁵, C. Marboe⁵, Y. Naka⁶, S. Restaino¹, P. C. Colombo³, L. J. Addonizio², M. A. Farr³, E. Zorn¹
Diagnostic Efficacy of Color Doppler Ultrasound on Recipients with Transplanted Renal Artery Stenosis: A Single Center Experience

Y. Yang, Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tao, M. Gu
Dialysis Facility Profit Status and Referral for Kidney Transplantation

E. R. Walker¹, L. J. McPherson¹, J. C. Gander², S. Pastan¹, R. E. Patzer¹
Dialysis Facility Provider Transplant Knowledge after a Randomized Multilevel Intervention to Increase Kidney Transplant Referral and Evaluation in the Southeast

K. Maroney¹, R. Hamoda¹, L. McPherson¹, A. Cruz², S. Pastan¹, L. Plantinga¹, S. Paul¹, M. Ellis³, D. DuBay⁴, A. Reeves-Daniel⁵, R. Detwiler⁶, E. Hartmann⁷, H. Jones⁸, B. Thrasher⁹, C. Zayas¹⁰, L. Mulloy¹⁰, S. Wright¹¹, R. Patzer¹
Dialysis Lowers Pulmonary Embolism Mortality Risk in Kidney Transplantation

B. Javaid, A. Gilbert, G. Vranic, J. Moore, B. Thomas, P. Abrams, S. Ghasemian, J. Verbesey, S. Yi, M. Cooper
Diastolic Blood Pressure Derived from Twenty Four Hour Ambulatory Blood Pressure Monitoring Predicts Survival after Kidney Transplantation

l. Basdeo, H. Wadei, M. Prendergast, M. Mai, C. Oshel, T. Jarmi
Dichotomous Role Of Donor T Cells In The Efficacy Of Tolerogenic Therapies For Transplant Rejection

M. Iglesias Lozano, D. Bibicheff, M. Chicco, G. Brandacher, G. Raimondi
Did COIIN Cohort A Maintain Graft Survival Performance While Increasing Moderate to High KDPI Transplants?

J. Foutz, R. J. Carrico, K. Sisaithong, H. Tosoc-Haskell, D. Klassen
Difference in DSA Formation between Tacrolimus-XR and Tacrolimus-IR

J. Hagopian¹, C. Carthon¹, S. January¹, A. Gharabagi², R. Delos Santos³, T. Horwedel⁴
Differences in CMV-Specific CD4 T Cell Population in De Novo Kidney Transplant Recipients Treated with Everolimus-Based Regimen Compared to a Standard Tacrolimus-MPA Regimen: Results from ATHENA

I. A. Hauser¹, S. Marx¹, C. Sommerer¹, B. Suwelack¹, D. Dragun¹, O. Witzke¹, F. Lehner¹, I. Kroeger², M. Junge², F. Thaiss¹, B. Nashan¹, M. Sester¹